Overview

Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting Conditions

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
To compare the single-dose Bioavailability of Tranylcypromine and Parnate
Phase:
Phase 1
Details
Lead Sponsor:
Par Pharmaceutical, Inc.
Collaborator:
SFBC Ft. Myers, Inc
Treatments:
Tranylcypromine